ATRC
Price
$54.54
Change
+$1.58 (+2.98%)
Updated
Sep 11 closing price
Capitalization
2.78B
53 days until earnings call
Intraday BUY SELL Signals
CERS
Price
$2.49
Change
+$0.03 (+1.22%)
Updated
Sep 11 closing price
Capitalization
501.8M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ATRC vs CERS

ATRC vs CERS Comparison Chart in %
View a ticker or compare two or three
VS
ATRC vs. CERS commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Hold and CERS is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATRC($2.78B) has a higher market cap than CERS($502M). ATRC YTD gains are higher at: 37.867 vs. CERS (20.874). ATRC has higher annual earnings (EBITDA): 38.6M vs. CERS (2.91M). ATRC has more cash in the bank: 168M vs. CERS (56.3M). ATRC has less debt than CERS: ATRC (71M) vs CERS (76.8M). ATRC has higher revenues than CERS: ATRC (570M) vs CERS (222M).
ATRCCERSATRC / CERS
Capitalization2.78B502M553%
EBITDA38.6M2.91M1,327%
Gain YTD37.86720.874181%
P/E Ratio259.90N/A-
Revenue570M222M257%
Total Cash168M56.3M298%
Total Debt71M76.8M92%
FUNDAMENTALS RATINGS
ATRC vs CERS: Fundamental Ratings
ATRC
CERS
OUTLOOK RATING
1..100
7866
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
39
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8894
PRICE GROWTH RATING
1..100
3539
P/E GROWTH RATING
1..100
11100
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (39) in the Medical Specialties industry is somewhat better than the same rating for ATRC (81). This means that CERS’s stock grew somewhat faster than ATRC’s over the last 12 months.

CERS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ATRC (100). This means that CERS’s stock grew similarly to ATRC’s over the last 12 months.

ATRC's SMR Rating (88) in the Medical Specialties industry is in the same range as CERS (94). This means that ATRC’s stock grew similarly to CERS’s over the last 12 months.

ATRC's Price Growth Rating (35) in the Medical Specialties industry is in the same range as CERS (39). This means that ATRC’s stock grew similarly to CERS’s over the last 12 months.

ATRC's P/E Growth Rating (11) in the Medical Specialties industry is significantly better than the same rating for CERS (100). This means that ATRC’s stock grew significantly faster than CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRCCERS
RSI
ODDS (%)
Bearish Trend 4 days ago
73%
Bullish Trend 5 days ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 11 days ago
69%
Bullish Trend 18 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
77%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
87%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (ATRC: $54.54 vs. CERS: $2.49)
Brand notoriety: ATRC and CERS are both not notable
ATRC represents the Pharmaceuticals: Other, while CERS is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ATRC: 106% vs. CERS: 69%
Market capitalization -- ATRC: $2.78B vs. CERS: $501.8M
ATRC [@Pharmaceuticals: Other] is valued at $2.78B. CERS’s [@Medical/Nursing Services] market capitalization is $501.8M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $130.41B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $1.86K to $176.41B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.43B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 1 FA rating(s) are green while CERS’s FA Score has 0 green FA rating(s).

  • ATRC’s FA Score: 1 green, 4 red.
  • CERS’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATRC and CERS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 4 TA indicator(s) are bullish while CERS’s TA Score has 3 bullish TA indicator(s).

  • ATRC’s TA Score: 4 bullish, 3 bearish.
  • CERS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ATRC is a better buy in the short-term than CERS.

Price Growth

ATRC (@Pharmaceuticals: Other) experienced а +5.86% price change this week, while CERS (@Medical/Nursing Services) price change was -3.86% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.51%. For the same industry, the average monthly price growth was -3.46%, and the average quarterly price growth was +12.67%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was -6.66%.

Reported Earning Dates

ATRC is expected to report earnings on Nov 04, 2026.

CERS is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-5.01% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
ATRC
Daily Signal:
Gain/Loss:
CERS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGIAX48.80N/A
N/A
MFS International Intrinsic Equity A
FHCIX73.98N/A
N/A
Fidelity Advisor Health Care I
SGGAX83.17N/A
N/A
DWS Large Cap Focus Growth A
GSMSX37.51N/A
N/A
Goldman Sachs Mid Cap Value Svc
WDIIX17.13N/A
N/A
Wilmington Enhanced Div Inc Strat I

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with ICUI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+1.22%
ICUI - CERS
46%
Loosely correlated
-0.50%
UTMD - CERS
45%
Loosely correlated
+0.10%
BLFS - CERS
45%
Loosely correlated
+0.09%
RVTY - CERS
44%
Loosely correlated
+2.79%
ATRC - CERS
43%
Loosely correlated
+2.98%
More